Persons with both opioid use disorder (OUD) and chronic pain face mental health challenges, poor substance use prognosis, and compromised quality of life. One way to improve outcomes in this vulnerable patient population is to enhance health literacy, particularly literacy regarding opioid medications. A fundamental metric of such literacy is whether persons with OUD can correctly identify medications, including those prescribed for OUD, as opioids. This question has yet to be researched extensively.
Methods:
Participants were 163 adults with OUD and chronic pain receiving buprenorphine treatment who provided information about demographics and substance use history and classified 17 select medications and psychoactive substances as opioids or non-opioids.
Results:
Nearly all study participants correctly identified most assessed medications and other psychoactive substances as (non-)opioids but were less able to identify medications for OUD. Only two thirds of the sample correctly identified buprenorphine, a medication they were currently taking, as an opioid. In general, greater opioid identification was associated with greater use of substances (including opioids) and a history of drug overdose.
Conclusion:
These findings underscore the need to enhance opioid medication literacy, especially in persons with less opioid use experience, in order to prevent some of its more deadly consequences.
Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2021 National Survey on Drug Use and Health (HHS Publication No. PEP22-07-01-005, NSDUH Series H-57). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. 2022. Accessed October 15, 2024. https://www.samhsa.gov/data/report/2021-nsduh-annual-national-report
2.
TsuiJILiraMCChengDM, et alChronic pain, craving, and illicit opioid use among patients receiving opioid agonist therapy. Drug Alcohol Depend. 2016;166:26-31. doi:10.1016/j.drugalcdep.2016.06.024
3.
MillsSEENicolsonKPSmithBH. Chronic pain: a review of its epidemiology and associated factors in population-based studies. Br J Anaesth. 2019;123(2):e273-e283. doi:10.1016/j.bja.2019.03.023
4.
OutcaltSDKroenkeKKrebsEE, et alChronic pain and comorbid mental health conditions: independent associations of posttraumatic stress disorder and depression with pain, disability, and quality of life. J Behav Med. 2015;38:535-543. doi:10.1007/s10865-9628-3
5.
De AquinoJPParidaSAvila-QuinteroVJ, et alOpioid-induced analgesia among persons with opioid use disorder receiving methadone or buprenorphine: a systematic review of experimental pain studies. Drug Alcohol Depend. 2020;228:109097. doi:10.1016/j.drugalcdep.2021.109097
6.
EdwardsKAVowlesKEMcHughRKVennerKLWitkiewitzK.Changes in pain during buprenorphine maintenance treatment among patients with opioid use disorder and chronic pain. J Consult Clin Psychol. 2022;90:314-325. doi:10.1037/ccp0000692
7.
MacLeanRRSofuogluMStefanovicsERosenheckR.Opioid use disorder with chronic pain increase disease burden and service use. Psychol Serv. 2023;20:157-165. doi:10.1037/ser0000607
8.
FergusonELewisBTeitelbaumSReisfieldGRobinsonMBoissoneaultJ.Longitudinal associations between pain and substance use disorder treatment outcomes. J Subst Abuse Treat. 2020;143:108892. doi:10.1016/j.jsat.2022.108892
9.
LiuCWangDLiuC, et alWhat is the meaning of health literacy? A systematic review and qualitative synthesis. Fam Med Community Health. 2020;8:e000351. doi:10.1136/fmch-2020-000351
10.
KimKYangYWangZ, et alA systematic review of the association between health literacy and pain self-management. Patient Educ Couns. 2022;105:1427-1440. doi:10.1016/j.pec/2021.09.037
11.
McAnallyKHaggerMS.Health literacy, social cognition constructs, and health behaviors and outcomes: a meta-analysis. Health Psychol. 2023;42:213-234. doi:10.1037/hea0001266
12.
HughesLWhittleseaCLuscombeD.Patients’ knowledge and perceptions of the side-effects of OTC medication. J Clin Pharm Ther. 2002;27(4):243-248. doi:10.1046/j.1365-2710.2002.00416.x
13.
HannaLHughesCM.Public’s views on making decisions about over-the-counter medication and their attitudes toward evidence of effectiveness: a cross-sectional questionnaire study. Patient Educ Couns. 2011;83:345-351. doi:10.1016/j.pec2011.02.016
14.
CooperRJ.Over-the-counter medicine abuse—a review of the literature. J Subst Use. 2013;13:82-107. doi:10.3109/14659891.2011.615002
15.
WangTChangFLeeCChiHHuanLTsengC.Adolescents’ misperceptions and low literacy associated with the inappropriate use of over-the-counter cole medicines. J Subst Use. 2020;25:101-106. doi:10.1080/14659891.2019.1664661
16.
DunnKEBarrettFSYepez-LaubachC, et alOpioid overdose experience, risk behaviors, and knowledge in drug users from a rural versus an urban setting. J Subst Abuse Treat. 2016;71:1-7. doi:10.1016/j.jsat.2016.08.006
17.
JonesJDCampbellANBrandtL, et alA randomized clinical trial of the effects of brief versus extended opioid overdose education on naloxone utilization outcomes by individuals with opioid use disorder. Drug Alcohol Depend. 2022;237:109505. doi:10.1016/j.drugalcdep.2022.109505
18.
WilderCMMillerSCTiffanyEWinhusenTWinstanleyELSteinMD.Risk factors for opioid overdose and awareness of overdose risk among veterans prescribed chronic opioids for addiction or pain. J Addict Dis. 2016;35(1):42-51. doi:10.1080/10550887.2016.1107264
19.
YarboroughBJHStumboSPJanoffSL, et alUnderstanding opioid overdose characteristics involving prescription and illicit opioids: a mixed methods analysis. Drug Alcohol Depend. 2016;167:49-56. doi:10.1016/j.drugalcdep.2016.07.024
20.
DunnKEYepez-LaubachCNuzzoPA, et alRandomized controlled trial of a computerized opioid overdose education intervention. Drug Alcohol Depend. 2017;173:S39-S47. http://dx.doi.org/10.1016/j.drugalcdep.2016.12.003
21.
BergeriaCLHuhnASDunnKE.Randomized comparison of two web-based interventiosn on immediate and 30-day opioid overdose knowledge in three unique risk groups. Prev Med. 2019:128:105718. doi:10.1016/j.ypmed.2019.05.006
22.
HollanderMAGChangCHDouaihyABHulseyEDonohueJM. Racial inequality in medication treatment for opioid use disorder: exploring potential facilitators and barriers to use. Drug Alcohol Depend. 2021;227:108927. doi:10.1016/j.drugalcdep.2021.108927
23.
StahlerGJMennisJBaronDA.Racial/ethnic disparities in the use of medications for opioid use disorder (MOUD) and their effects on residential drug treatment outcomes in the US. Drug Alcohol Depend. 2021;226:108849. http://doi.org.10.1016/j.drugalcdep.2021.108849
24.
TaylorBGLamudaPAFlanaganEWattsEPollackHSchneiderJ. Social stigma toward persons with opioid use disorder: results from a nationally representative survey of U.S. adults. Subst Use Misuse. 2021;56:1752-1764. doi:10.1080/10826084.2021.1949611
25.
GarpenhagLDahlmanD.Perceived healthcare stigma among patients in opioid substitution treatment: a qualitative study. Subst Abuse Treat Prev Policy. 2021;16:81. doi:10.1186/s13011-021-00417-3
26.
FotiKHeywardJTajanlangitM, et alPrimary care physicians’ preparedness to treat opioid use disorder in the United States: a cross-sectional survey. Drug Alcohol Depend. 2021;205:108811. doi:10.1016/j.drugalcdep.2021.108811
27.
GraySLFornaroRTurnerJ, et alProvider knowledge, beliefs, and self-efficacy to deprescribe opioids and sedative-hypnotics. J Am Geriatr Soc. 2022;71:1580-1586. doi:10.1111/jgs.18202
28.
JakubowskiASingh-TanSTorres-LockhartK, et alHospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation. Addict Sci Clin Pract. 2023;18:31. doi:10.1186/s13722-023-00386-x
29.
HwangCSTurnerLWKruszewskiSPKolodnyAAlexanderGC.Primary care physicians’ knowledge and attitudes regarding prescription opioid abuse and diversion. Clin J Pain. 2016;32:279-284. doi:10.1097/AJP.0000000000000268
30.
BascouNAHaslund-GourleyBAmber-MontaK, et alReducing the stigma surrounding opioid use disorder: evaluating an opioid overdose prevention training program applied to a diverse population. Harm Reduct J. 2022;19:5. doi:10.1186/s12954-022-00589-6
31.
MosesTEHChouJSMorenoJLLundahlLHWaineoEGreenwaldMK. Long-term effects of opioid overdose prevention and response training on medical student knowledge and attitudes toward opioid overdose: a pilot study. Addict Behav. 2022;126:107172. doi:10.1016/j.addbeh.2021.107172
32.
PalamarJJ.Barriers to accurately assessing prescription opioid misuse on surveys. Am J Drug Alcohol Abuse. 2019;45:117-123. doi:10.1080/00952990.2017.1521826
33.
CleelandCSRyanKM.Pain assessment: global use of the brief pain inventory. Ann Acad Med. 1994;23(2):129-113.
34.
KroenkeKSpitzerRLWilliamsJBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613. doi:10.1046/j.1525-1497.2001.016009606.x
35.
McLellanATLuborskyLWoodyGEO’BrienCP.An improved diagnostic evaluation instrument for substance abuse patients: the Addiction Severity Index. J Nerv Ment Dis. 1980;168:26-33. doi:10.1097/00005053-198001000-00006
36.
JonesJD.Opioid overdose knowledge among college students compared to experienced opioid users. Drug Alcohol Rev. 2024;43:343-346. doi:10.1111/dar.13770
37.
McHughRKNguyenMDChartoffEHSugarmanDEGreenfieldSF.Gender differences in the prevalence of heroin and opioid analgesic misuse in the United States, 2015-2019. Drug Alcohol Depend. 2021;227:108978. doi:10.1016/j.drugalcdep.2021.108978
38.
ShaidooBBaheshmatSRostam-AbadiYShakeriAGholamiJRahimi-MovagharA.Comparison of self-reported substance use with biological testing among treatment-seeking patients with opioid use disorder. J Subst Abuse Treat. 2022;134:108555. doi:10.1016/jsat.2021.108555
39.
RogersAHBakhshaieJOrrMFDitreJWZvolenskyMJ.Health literacy, opioid misuse, and pain experience among adults with chronic pain. Pain Med. 2020;21(4): 670-676. doi:10.1093/pm/pnz062
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
